RxDoctor Payments DataLook up a doctor →

Elizabeth Tourville, MD

Urology · Phoenix, AZNPI 1841610003

Payments from drug & device makers

$13,832in general payments, 2019–2025

Across 415 payments — averaging $33.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$5K
  • Coloplast$2K
  • Boston Scientific$903
  • AbbVie$897
  • Sumitomo Pharma America, Inc.$743
  • Teleflex LLC$731
  • plus $4K from 37 others

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Axonics, Inc.67$4,558
Coloplast52$1,897
Boston Scientific26$903
AbbVie(2 entities)49$897
Sumitomo Pharma America, Inc.27$743
Teleflex LLC11$731
Pfizer27$530
Johnson & Johnson24$526
Astellas Pharma US Inc19$306
Dendreon Pharmaceuticals LLC15$265
Laborie Medical Technologies Corp.5$249
Olympus America Inc.5$202
Progenics Pharmaceuticals, Inc.6$158
C. R. Bard, Inc. & Subsidiaries5$134
Innovation Technologies Inc2$130
Novartis5$129
Antares Pharma, Inc.8$125
Bayer8$124
Medtronic2$113
Ferring Pharmaceuticals Inc.6$109
Urogen Pharma, Inc.5$84
Calyxo, Inc.1$82
AstraZeneca3$68
Merck3$65
Ambu Inc.3$62
Urovant Sciences Inc3$60
180 Medical, Inc.3$58
Tolmar, Inc.3$58
Myriad Genetic Laboratories, Inc.3$56
Vertex2$51
Smith+Nephew2$46
Procept Biorobotics Corporation1$45
Blue Earth Diagnostics2$38
Clarus Therapeutics Inc.2$38
Accord Healthcare, Inc.2$33
Tolmar Pharmaceuticals, Inc.1$27
Cycle Pharmaceuticals Inc1$25
Myovant Sciences Inc.1$23
Endo USA, Inc.1$20
Halozyme Inc1$19
Verity Pharmaceuticals Inc.1$17
Immunitybio, Inc.1$15
Coopersurgical, Inc.1$14

How this compares

$13,832 in reported general payments places this provider in the 75th percentile of 269 urology providers in Arizona.

See all urology providers in Arizona →

Medicare billing

Part B allowed, 2024
$212,737
Medicare patients
416
Services billed
5,116

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Phoenix

See the full list for Arizona →

Where these figures come from

Is this you, or does something look wrong? →